Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Association of race and ethnicity with withdrawal symptoms, attrition, opioid use, and side-effects during buprenorphine therapy.

Brown ES, Tirado C, Minhajuddin A, Hillhouse M, Adinoff B, Ling W, Doraimani G, Thomas C.

J Ethn Subst Abuse. 2010;9(2):106-14. doi: 10.1080/15332641003772587.

PMID:
20509084
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Effects of ethnicity on low-dose opiate stabilization.

Kosten TR, Rayford BS.

J Subst Abuse Treat. 1995 Mar-Apr;12(2):111-6.

PMID:
7623388
[PubMed - indexed for MEDLINE]
3.

Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.

Ziedonis DM, Amass L, Steinberg M, Woody G, Krejci J, Annon JJ, Cohen AJ, Waite-O'Brien N, Stine SM, McCarty D, Reid MS, Brown LS Jr, Maslansky R, Winhusen T, Babcock D, Brigham G, Muir J, Orr D, Buchan BJ, Horton T, Ling W.

Drug Alcohol Depend. 2009 Jan 1;99(1-3):28-36. doi: 10.1016/j.drugalcdep.2008.06.016. Epub 2008 Sep 20.

PMID:
18805656
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.

Amass L, Ling W, Freese TE, Reiber C, Annon JJ, Cohen AJ, McCarty D, Reid MS, Brown LS, Clark C, Ziedonis DM, Krejci J, Stine S, Winhusen T, Brigham G, Babcock D, Muir JA, Buchan BJ, Horton T.

Am J Addict. 2004;13 Suppl 1:S42-66.

PMID:
15204675
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study.

Chakrabarti A, Woody GE, Griffin ML, Subramaniam G, Weiss RD.

Drug Alcohol Depend. 2010 Mar 1;107(2-3):253-6. doi: 10.1016/j.drugalcdep.2009.10.014. Epub 2009 Nov 30.

PMID:
19948382
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Comparison of behavioral treatment conditions in buprenorphine maintenance.

Ling W, Hillhouse M, Ang A, Jenkins J, Fahey J.

Addiction. 2013 Oct;108(10):1788-98. doi: 10.1111/add.12266. Epub 2013 Jul 12.

PMID:
23734858
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

From research to the real world: buprenorphine in the decade of the Clinical Trials Network.

Ling W, Jacobs P, Hillhouse M, Hasson A, Thomas C, Freese T, Sparenborg S, McCarty D, Weiss R, Saxon A, Cohen A, Straus M, Brigham G, Liu D, McLaughlin P, Tai B.

J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S53-60. doi: 10.1016/j.jsat.2010.01.009.

PMID:
20307796
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience.

Alford DP, LaBelle CT, Kretsch N, Bergeron A, Winter M, Botticelli M, Samet JH.

Arch Intern Med. 2011 Mar 14;171(5):425-31. doi: 10.1001/archinternmed.2010.541.

PMID:
21403039
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Participant characteristics and buprenorphine dose.

Hillhouse M, Canamar CP, Doraimani G, Thomas C, Hasson A, Ling W.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):453-9. doi: 10.3109/00952990.2011.596974.

PMID:
21854290
[PubMed - indexed for MEDLINE]
Free PMC Article
10.
11.

Buprenorphine for the management of opioid withdrawal.

Gowing L, Ali R, White J.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD002025. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD002025.

PMID:
15495026
[PubMed - indexed for MEDLINE]
12.

Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients.

McCance-Katz EF, Moody DE, Prathikanti S, Friedland G, Rainey PM.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):326-34. doi: 10.1016/j.drugalcdep.2011.04.013. Epub 2011 May 19.

PMID:
21596492
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine.

Tompkins DA, Smith MT, Mintzer MZ, Campbell CM, Strain EC.

J Pharmacol Exp Ther. 2014 Feb;348(2):217-26. doi: 10.1124/jpet.113.209478. Epub 2013 Nov 13.

PMID:
24227768
[PubMed - indexed for MEDLINE]
14.

Buprenorphine for the management of opioid withdrawal.

Gowing L, Ali R, White J.

Cochrane Database Syst Rev. 2000;(3):CD002025. Review. Update in: Cochrane Database Syst Rev. 2002;(2):CD002025.

PMID:
10908521
[PubMed - indexed for MEDLINE]
15.

A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals.

Amass L, Pukeleviciene V, Subata E, Almeida AR, Pieri MC, D'Egidio P, Stankova Z, Costa A, Smyth BP, Sakoman S, Wei Y, Strang J.

Addiction. 2012 Jan;107(1):142-51. doi: 10.1111/j.1360-0443.2011.03577.x. Epub 2011 Oct 12.

PMID:
21749526
[PubMed - indexed for MEDLINE]
16.

Buprenorphine for the management of opioid withdrawal.

Gowing L, Ali R, White J.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002025. Review. Update in: Cochrane Database Syst Rev. 2009;(3):CD002025.

PMID:
16625553
[PubMed - indexed for MEDLINE]
17.
18.

Buprenorphine for the management of opioid withdrawal.

Gowing L, Ali R, White J.

Cochrane Database Syst Rev. 2002;(2):CD002025. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD002025.

PMID:
12076434
[PubMed - indexed for MEDLINE]
19.

Buprenorphine for the management of opioid withdrawal.

Gowing L, Ali R, White JM.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD002025. doi: 10.1002/14651858.CD002025.pub4. Review.

PMID:
19588330
[PubMed - indexed for MEDLINE]
20.

Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.

Magnelli F, Biondi L, Calabria R, Fiore A, Peluso E, Vonella D, Rota AG.

Clin Drug Investig. 2010;30 Suppl 1:21-6. doi: 10.2165/11536010-000000000-00000.

PMID:
20450242
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk